Testimonials

It is very nice to visit Lambda facility and thanks to warm welcome provided by all the teams. I can easily say one of the best CRO I ever visited. People here are wonderful and doing great job

Reputed Client of Israel

Awesome hospitality & fantastic office. All the best!

Reputed Client of Japan

Excellent hospitality and cooperation received throughout the audit. People are knowledgeable and extremely transparent. Looking for long time relation

Reputed Client of Asia

Facility is too good to conduct the BABE studies and adherence to protocol and quality assurance in conducting studies are meeting sponsor expectations and requirements.

Reputed Client of India

Facility is good, people r trained well and know the subject on which they r working. All the best.

Reputed Client of USA

Highly innovative and advanced research centre that possess bright future for the development of the country.

Reputed International Government Body

It is one of the best facility in India for BA/BE

Reputed Regulatory Authority

Lambda is a very professional CRO. All the staff here are experienced and very knowledgeable. I'm grateful for their accommodations and hospitality. The future, if we want to carry out BE study, we will ask Lambda help again.

Reputed Client of Europe

It was a really pleasant meeting with the PV department, and I am looking forward to the next visit.

Reputed Client of Europe

Amazing and best CRO I ever seen

Reputed Client of China

Blog

Blog/BA/BE

Home / Blog

WHO Expert Committee (Fiftieth report): Clinical recommendat...

08 Jul 2019

WHO has recently released a guideline for performing in vivo bioequivalence studies (WHO Technical Report Series 996, 2016). The guideline mainly emph...

Read More



Clinical Research: A Tool to Support Nutraceutical Product C...

03 Jun 2019

Nutraceuticals are the products that have both nutritional and pharmaceutical characters. Therefore they are used as a dietary supplement to modulate ...

Read More



REMS/RMP Requirement and its Consideration in Clinical Studi...

05 May 2019

Drugs used in therapeutic treatments have associated potential risks for adverse events (AE). Nevertheless, medical practitioners acknowledge such ris...

Read More



WHO Draft Guidance for Organizations Performing In Vivo Bioe...

07 Mar 2019

The guidance covers major amendments; the points regarding the clinical study part are mentioned below: The CRF should be sent to the IEC for review...

Read More



PHASE-0 (MICRO-DOSING): A NEW APPROACH

08 Apr 2018

Developing and launching a new pharmaceutical drug to the market is an immensely expensive operation. Pharmaceutical scientists and physicians are con...

Read More



FDA DRAFT GUIDANCE for recording "Minutes of Institutional R...

06 Mar 2018

I. IRB must prepare and maintain adequate documentation of IRB activities, including minutes (MOM) in sufficient detail to show: Attendance, actions b...

Read More



BE Studies of Inhaled Drug Products - Challenges and Strateg...

06 Mar 2018

In the recent disease management scenario, inhaled drug products are playing a significant role in therapeutics. Inhalational route of drug delivery h...

Read More



Looking for a Globally Proven Research Partner?

Contact Us